Clinical Trial Update: Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating cabergoline for coasting to reduce the incidence of ovarian hyperstimulation syndrome; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Tanta University | Conditions: Gynecologic Disease | Phase 2 | Status: RECRUITING